<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JCN</journal-id>
<journal-id journal-id-type="hwp">spjcn</journal-id>
<journal-id journal-id-type="nlm-ta">J Child Neurol</journal-id>
<journal-title>Journal of Child Neurology</journal-title>
<issn pub-type="ppub">0883-0738</issn>
<issn pub-type="epub">1708-8283</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0883073811420296</article-id>
<article-id pub-id-type="publisher-id">10.1177_0883073811420296</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Brief Communications</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Phosphatase and Tensin Homolog (PTEN) Gene Mutations and Autism: Literature Review and a Case Report of a Patient With Cowden Syndrome, Autistic Disorder, and Epilepsy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Conti</surname>
<given-names>Sara</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0883073811420296">1</xref></contrib>
<contrib contrib-type="author">
<name>
<surname>Condò</surname>
<given-names>Maria</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0883073811420296">1</xref></contrib>
<contrib contrib-type="author">
<name>
<surname>Posar</surname>
<given-names>Annio</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0883073811420296">1</xref></contrib>
<contrib contrib-type="author">
<name>
<surname>Mari</surname>
<given-names>Francesca</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073811420296">2</xref></contrib>
<contrib contrib-type="author">
<name>
<surname>Resta</surname>
<given-names>Nicoletta</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff3-0883073811420296">3</xref></contrib>
<contrib contrib-type="author">
<name>
<surname>Renieri</surname>
<given-names>Alessandra</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-0883073811420296">2</xref></contrib>
<contrib contrib-type="author">
<name>
<surname>Neri</surname>
<given-names>Iria</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-0883073811420296">4</xref></contrib>
<contrib contrib-type="author">
<name>
<surname>Patrizi</surname>
<given-names>Annalisa</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-0883073811420296">4</xref></contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Parmeggiani</surname>
<given-names>Antonia</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-0883073811420296">1</xref>
<xref ref-type="corresp" rid="corresp1-0883073811420296"/>
</contrib>
</contrib-group>
<aff id="aff1-0883073811420296"><label>1</label>Child Neurology and Psychiatry Unit, Department of Neurological Sciences, University of Bologna, Italy</aff>
<aff id="aff2-0883073811420296"><label>2</label>Medical Genetics, Department of Biotechnology, University of Siena, Italy</aff>
<aff id="aff3-0883073811420296"><label>3</label>Medical Genetics, Department of Childhood Biomedicine, University of Bari Aldo Moro, Bari, Italy</aff>
<aff id="aff4-0883073811420296"><label>4</label>Department of Internal Medicine, Geriatrics and Nephrology, Division of Dermatology, University of Bologna, Italy</aff>
<author-notes>
<corresp id="corresp1-0883073811420296">Antonia Parmeggiani, MD, Department of Neurological Sciences, University of Bologna, via Ugo Foscolo 7, 40123 Bologna, Italy Email: <email>antonia.parmeggiani@unibo.it</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>27</volume>
<issue>3</issue>
<fpage>392</fpage>
<lpage>397</lpage>
<history>
<date date-type="received">
<day>13</day>
<month>7</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>21</day>
<month>7</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>7</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Phosphatase and tensin homolog (PTEN) gene mutations are associated with a spectrum of clinical disorders characterized by skin lesions, macrocephaly, hamartomatous overgrowth of tissues, and an increased risk of cancers. Autism has rarely been described in association with these variable clinical features. At present, 24 patients with phosphatase and tensin homolog gene mutation, autism, macrocephaly, and some clinical findings described in phosphatase and tensin homolog syndromes have been reported in the literature. We describe a 14-year-old boy with autistic disorder, focal epilepsy, severe and progressive macrocephaly, and multiple papular skin lesions and palmoplantar punctate keratoses, characteristic of Cowden syndrome. The boy has a de novo phosphatase and tensin homolog gene mutation. Our patient is the first case described to present a typical Cowden syndrome and autism associated with epilepsy.</p>
</abstract>
<kwd-group>
<kwd>phosphatase and tensin homolog gene</kwd>
<kwd>PTEN</kwd>
<kwd>Cowden syndrome</kwd>
<kwd>autism</kwd>
<kwd>macrocephaly</kwd>
<kwd>epilepsy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Phosphatase and tensin homolog (PTEN) tumor suppressor on chromosome 10 gene encodes a dual-specificity phosphatase that mediates cell cycle arrest and apoptosis; it is localized on chromosome band 10q23. Phosphatase and tensin homolog germline mutations have been implicated in a group of related tumor syndromes with autosomal dominant inheritance and highly variable expression, known as the “phosphatase and tensin homolog hamartoma tumor syndromes,” and including Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, Proteus syndrome and Proteus-like conditions, Lhermitte-Duclos disease, and Juvenile Polyposis syndrome. These syndromes may present different symptoms affecting the central nervous system, the skin, and the intestine with increased risk for malignancies.<sup><xref ref-type="bibr" rid="bibr1-0883073811420296">1</xref></sup>
</p>
<p>Cowden syndrome is a multisystem disorder involving increased risk for malignancies, especially breast and thyroid cancer, benign hamartomatous overgrowth of mucocutaneous, breast, thyroid, or intestinal tissues and macrocephaly. Skin lesions and hamartomas usually appear by the age of 20 years. In 2008 the National Comprehensive Cancer Network revised the Cowden syndrome diagnostic criteria proposing the use of pathognomonic, major and minor criteria (<xref ref-type="table" rid="table2-0883073811420296">Table 1</xref>). An accurate clinical observation, with a careful and regular surveillance of affected patients, is necessary to evaluate the risk of developing malignancies.<sup><xref ref-type="bibr" rid="bibr2-0883073811420296">2</xref></sup>
</p>
<table-wrap id="table1-0883073811420296" position="float">
<label>Table 1.</label>
<caption>
<p>Cowden Syndrome Diagnostic Criteria—National Comprehensive Cancer Network, 2008</p>
</caption>
<graphic alternate-form-of="table1-0883073811420296" xlink:href="10.1177_0883073811420296-table2.tif"/>
<table>
<thead>
<tr>
<th>
</th>
<th>Criteria</th>
<th>Operational diagnosis</th>
</tr>
</thead>
<tbody>
<tr>
<td>Pathognomonic criteria</td>
<td>
<list list-type="bullet">
<list-item>
<p>Adult Lhermitte-Duclos disease</p>
</list-item>
<list-item>
<p>Mucocutaneous lesions: Trichilemmomas, Facial acral keratoses, Papillomatous lesions</p>
</list-item>
</list>
</td>
<td rowspan="3">Any of the following: <list list-type="order">
<list-item>
<p>Mucocutaneous lesions alone if: <list list-type="alpha-lower">
<list-item>
<p>There are 6 or more facial papules, of which 3 or more must be trichilemmoma, or</p>
</list-item>
<list-item>
<p>Cutaneous facial papules and oral mucosal papillomatosis, or</p>
</list-item>
<list-item>
<p>Oral mucosus papillomatosis and acral keratoses, or</p>
</list-item>
<list-item>
<p>Palmoplantar keratoses, 6 or more</p>
</list-item>
</list>
</p>
</list-item>
<list-item>
<p>Two or more major criteria, but 1 must include macrocephaly or adult Lhermitte-Duclos disease; or</p>
</list-item>
<list-item>
<p>One major and 3 minor criteria; or</p>
</list-item>
<list-item>
<p>Four minor criteria</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td>Major criteria</td>
<td>
<list list-type="bullet">
<list-item>
<p>Breast cancer</p>
</list-item>
<list-item>
<p>Thyroid cancer (papillary or follicular)</p>
</list-item>
<list-item>
<p>Macrocephaly (≥97th percentile)</p>
</list-item>
<list-item>
<p>Endometrial cancer</p>
</list-item>
</list>
</td>
</tr>
<tr>
<td>Minor criteria</td>
<td>
<list list-type="bullet">
<list-item>
<p>Other structural thyroid lesions (eg., adenoma, multinodular goiter)</p>
</list-item>
<list-item>
<p>Mental retardation (ie, IQ ≤ 75)</p>
</list-item>
<list-item>
<p>Gastrointestinal hamartomas</p>
</list-item>
<list-item>
<p>Fibrocystic disease of the breast</p>
</list-item>
<list-item>
<p>Lipomas</p>
</list-item>
<list-item>
<p>Fibromas</p>
</list-item>
<list-item>
<p>Genitourinary tumors (eg., uterine fibroids, renal cell carcinoma) or</p>
</list-item>
<list-item>
<p>Genitourinary structural malformations</p>
</list-item>
<list-item>
<p>Uterine fibroids</p>
</list-item>
</list>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0883073811420296">
<p>Abbreviation: IQ, intelligence quotient.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Several recent reports have identified heterozygous germline phosphatase and tensin homolog gene mutations also in children with autism spectrum disorder, macrocephaly, and sometimes clinical features of hamartoma tumor syndromes. To date, 24 cases with these features and the following common clinical aspects have been described in the literature: prevalence of male gender; birth weight, length, and head circumference at upper limits; and association with a possible positive family history for phosphatase and tensin homolog gene mutations and/or familial macrocephaly.<sup><xref ref-type="bibr" rid="bibr3-0883073811420296">3</xref><xref ref-type="bibr" rid="bibr4-0883073811420296"/><xref ref-type="bibr" rid="bibr5-0883073811420296"/><xref ref-type="bibr" rid="bibr6-0883073811420296"/><xref ref-type="bibr" rid="bibr7-0883073811420296"/><xref ref-type="bibr" rid="bibr8-0883073811420296"/><xref ref-type="bibr" rid="bibr9-0883073811420296"/><xref ref-type="bibr" rid="bibr10-0883073811420296"/><xref ref-type="bibr" rid="bibr11-0883073811420296"/><xref ref-type="bibr" rid="bibr12-0883073811420296"/><xref ref-type="bibr" rid="bibr13-0883073811420296"/><xref ref-type="bibr" rid="bibr14-0883073811420296"/>–<xref ref-type="bibr" rid="bibr15-0883073811420296">15</xref></sup>
</p>
<p>A summary of the clinical pictures of the reported cases is provided in <xref ref-type="table" rid="table1-0883073811420296">Table 2</xref>; none of the patients reported in the literature so far met the clinical diagnostic criteria of Cowden syndrome. We point out that according to 2008 National Comprehensive Cancer Network criteria, the case described by Goffin in 2001 could not receive a diagnosis of Cowden syndrome. In fact he presented only one major (macrocephaly) and one minor (mental retardation) criterion.<sup><xref ref-type="bibr" rid="bibr7-0883073811420296">7</xref></sup> We mention that macrocephaly is relatively common in autism but usually without a dramatic trend. We describe the first patient with autistic disorder, severe and progressive macrocephaly, skin lesions, focal epilepsy, and a phosphatase and tensin homolog gene mutation who indeed meets the clinical diagnostic criteria of Cowden syndrome.</p>
<table-wrap id="table2-0883073811420296" position="float">
<label>Table 2.</label>
<caption>
<p>Clinical Features of 24 Patients Reported in Literature With Autism and Phosphatase and Tensin Homolog Gene Mutations</p>
</caption>
<graphic alternate-form-of="table2-0883073811420296" xlink:href="10.1177_0883073811420296-table1.tif"/>
<table>
<thead>
<tr>
<th>Characteristics</th>
<th align="center">
<italic>n</italic> or mean (range)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sex</td>
<td>
</td>
</tr>
<tr>
<td> Male</td>
<td>19</td>
</tr>
<tr>
<td> Female</td>
<td>5</td>
</tr>
<tr>
<td>Age (y, mo)</td>
<td align="center">4 y 3 mo (16 mo-18 y)</td>
</tr>
<tr>
<td>Birth</td>
</tr>
<tr>
<td> Weight (g) (<italic>n</italic> = 11)</td>
<td align="center">3344 (2721-5260)</td>
</tr>
<tr>
<td> Length (cm) (<italic>n</italic> = 6)</td>
<td>52.2 (49-54)</td>
</tr>
<tr>
<td> OFC (cm) (<italic>n</italic> = 4)</td>
<td>36.2 (34-39)</td>
</tr>
<tr>
<td>Hypotonia</td>
<td>4</td>
</tr>
<tr>
<td>Motor delay</td>
<td>12</td>
</tr>
<tr>
<td>Speech delay</td>
<td>13</td>
</tr>
<tr>
<td>Mental retardation</td>
<td>12</td>
</tr>
<tr>
<td>Autism spectrum disorder</td>
<td>
</td>
</tr>
<tr>
<td> Autism</td>
<td>19</td>
</tr>
<tr>
<td> Pervasive developmental disorder not otherwise specified</td>
<td>2</td>
</tr>
<tr>
<td> Autistic behavior</td>
<td>2</td>
</tr>
<tr>
<td> Asperger syndrome</td>
<td>1</td>
</tr>
<tr>
<td>Macrocephaly (cm) (<italic>n</italic> = 19)</td>
<td align="center">59 (54-63)</td>
</tr>
<tr>
<td>Seizures (infantile spasms, recurrent seizures)</td>
<td>1</td>
</tr>
<tr>
<td>Hands/feet malformations</td>
<td>
</td>
</tr>
<tr>
<td> Bilateral feet polydactyly</td>
<td>1</td>
</tr>
<tr>
<td> Lacked second toe</td>
<td>1</td>
</tr>
<tr>
<td> Preaxial polydactyly right hand</td>
<td>1</td>
</tr>
<tr>
<td>Skin lesions</td>
<td>
</td>
</tr>
<tr>
<td> Lipomas</td>
<td>4</td>
</tr>
<tr>
<td> Multiple nevi</td>
<td>2</td>
</tr>
<tr>
<td> Café au lait spots, mongolian blue patch</td>
<td>2</td>
</tr>
<tr>
<td> Café au lait macules</td>
<td>2</td>
</tr>
<tr>
<td>Penile macules</td>
<td>4</td>
</tr>
<tr>
<td>Gastrointestinal polyps</td>
<td>2</td>
</tr>
<tr>
<td>Thyroid disease</td>
<td>
</td>
</tr>
<tr>
<td> Goiter, thyroid carcinoma</td>
<td>1</td>
</tr>
<tr>
<td> Adenoma with Hürthle cells</td>
<td>1</td>
</tr>
<tr>
<td>Malignancies</td>
<td>
</td>
</tr>
<tr>
<td> Reactive nodular lymphoid hyperplasia of small and large intestinal mucosa</td>
<td>1</td>
</tr>
<tr>
<td>Inheritance</td>
<td>
</td>
</tr>
<tr>
<td>(<italic>n</italic> = 21)</td>
<td>
</td>
</tr>
<tr>
<td> De novo</td>
<td>10</td>
</tr>
<tr>
<td> Maternal</td>
<td>5</td>
</tr>
<tr>
<td> Paternal</td>
<td>6</td>
</tr>
<tr>
<td>Familial macrocephaly</td>
<td>
</td>
</tr>
<tr>
<td> Mother</td>
<td>4</td>
</tr>
<tr>
<td> Father</td>
<td>5</td>
</tr>
<tr>
<td> Mother and father</td>
<td>2</td>
</tr>
<tr>
<td> Mother and maternal grandmother</td>
<td>1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0883073811420296">
<p>Abbreviation: OFC, occipitofrontal circumference.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section1-0883073811420296">
<title>Case Report</title>
<p>The patient is a boy aged 14. His family history was positive for macrocephaly, dysthyroidism, gastrointestinal cancers, autism, and behavioral and psychiatric disorders (<xref ref-type="fig" rid="fig1-0883073811420296">Figure 1</xref>).</p>
<fig id="fig2-0883073811420296" position="float">
<label>Figure 1.</label>
<caption>
<p>Patient family tree.</p>
</caption>
<graphic alternate-form-of="fig2-0883073811420296" xlink:href="10.1177_0883073811420296-fig2.tif"/>
</fig>
<p>During pregnancy, the boy’s head circumference was at upper limits. He was born at term by induced delivery for absent uterine contractions and umbilical cord wrapped around the neck. His weight at birth was 3800 g (90th percentile), length 53 cm (75th-90th percentile), and head circumference 36 cm (90th percentile). His psychomotor development was normal except for a mild speech delay up to 36 months, when the parents noticed a language regression and a change in behavior characterized by loss of social interaction, stereotyped movements, and loss of eye contact. Within 5 years of age head circumference was upper 98th percentile (57.5 cm); at the age of 10 it was 59 cm (&gt;98th percentile). High-resolution karyotype and genetic tests for fragile X syndrome and for the 15q11.2 region were normal. Cerebral magnetic resonance imaging disclosed right periventricular hyperintensity probably due to a remote hypoxic-ischemic insult, confirmed by the second and third magnetic resonance imaging at ages 6 and 12, respectively. A genetic counseling and phosphatase and tensin homolog (PTEN) molecular analysis for point mutations and exon/gene deletions performed by a combination of denaturing high-performance liquid chromatography and multiple ligation-dependent probe amplification was performed when the patient was 6 years old and an exon 2 deletion was detected. The same deletion was not identified in the patient’s healthy parents and the healthy older sister.</p>
<p>When the boy was 8 years old, 2 focal epileptic seizures occurred during wakefulness. The first seizure was characterized by pallor and hypotonia; the second one by vomiting, cyanosis, hypotonia, and loss of contact, lasting some minutes. Electroencephalogram recordings showed focal spike-wave complexes over the left temporal regions. A treatment with valproic acid was started. After that, seizures no longer occurred.</p>
<p>At the clinical observation performed when the patient was 12 years old, he showed macrocephaly (&gt;98th percentile, 60 cm), dysmorphic signs as abducted auricular pavilions, prominent forehead, flat feet, knock-knee, multiple mucocutaneous papules, and palmoplantar punctate keratoses. Skin examination revealed flesh-colored lesions, 1 to 3 mm diameter, resembling flat warts localized on the dorsum of hands and feet and on the proximal upper extremities. Similar lesions affected the lips also. Translucent hard papules, 2 to 4 mm in diameter, with a central depression distributed symmetrically on the palms and soles were noted.</p>
<p>The language was absent; impairment of symbolic functions, several stereotyped movements (such as head banging, hand flapping, and body rocking) and a developmental disorder were evident. Neuropsychological evaluation showed an autistic disorder (Childhood Autism Rating Scale, Autism Diagnostic Observation Schedule) and a profound mental retardation according to the <italic>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision</italic> (Leiter-R Scale).</p>
<p>Electroencephalogram recording showed that paroxysmal multifocal spike-waves were diffuse and subcontinuous during sleep over the left frontocentrotemporal regions. Recently, a photoparoxysmal response was detected (<xref ref-type="fig" rid="fig2-0883073811420296">Figure 2</xref>).</p>
<fig id="fig1-0883073811420296" position="float">
<label>Figure 2.</label>
<caption>
<p>Electroencephalogram recording during non–rapid eye movement (NREM) sleep showing subcontinuous focal spike-waves over the left frontocentrotemporal regions; during wakefulness a photoparoxysmal response.</p>
</caption>
<graphic alternate-form-of="fig1-0883073811420296" xlink:href="10.1177_0883073811420296-fig1.tif"/>
</fig>
<p>Histological examination of a papule localized on the arm showed focal prominent epidermal hyperplasia that at its periphery is demarcated by elongated rete ridges; foci of wedge-shaped hypergranulosis with compact orthokeratosis; dilated vessels in the papillary dermis.</p>
<p>Skin lesions permitted diagnosis of Cowden syndrome<sup><xref ref-type="bibr" rid="bibr16-0883073811420296">16</xref></sup> (<xref ref-type="table" rid="table2-0883073811420296">Table 1</xref>). Laboratory testing revealed a moderate increase of thyrotrophin-stimulating hormone and free triiodothyronine and uncertain values for anti-endomysial antibodies with positivity for human leukocyte antigen (HLA) haplotypes (HLA-DQ2 and HLA-DQ8) associated with celiac disease. The patient presents either constipation or diarrhetic bowel. We suggested the recommended follow-up for increased risk of malignancies in Cowden syndrome.</p>
</sec>
<sec id="section2-0883073811420296">
<title>Discussion</title>
<p>Our patient is the first case described in the literature to present simultaneously Cowden syndrome, autistic disorder, and epilepsy. None of the patients affected by autism and reported in the literature to date met the clinical diagnostic criteria of Cowden syndrome, probably because they were too young (aged between 16 months and 18 years) and some pathognomonic signs, such as skin lesions and hamartomas, usually appear later.<sup><xref ref-type="bibr" rid="bibr3-0883073811420296">3</xref><xref ref-type="bibr" rid="bibr4-0883073811420296"/><xref ref-type="bibr" rid="bibr5-0883073811420296"/><xref ref-type="bibr" rid="bibr6-0883073811420296"/><xref ref-type="bibr" rid="bibr7-0883073811420296"/><xref ref-type="bibr" rid="bibr8-0883073811420296"/><xref ref-type="bibr" rid="bibr9-0883073811420296"/><xref ref-type="bibr" rid="bibr10-0883073811420296"/><xref ref-type="bibr" rid="bibr11-0883073811420296"/><xref ref-type="bibr" rid="bibr12-0883073811420296"/><xref ref-type="bibr" rid="bibr13-0883073811420296"/><xref ref-type="bibr" rid="bibr14-0883073811420296"/>–<xref ref-type="bibr" rid="bibr15-0883073811420296">15</xref></sup></p>
<p>In our case, the concurrent presence of severe and progressive macrocephaly and autism led us to investigate phosphatase and tensin homolog gene and later to study in depth skin lesions and to definitively make the diagnosis of Cowden syndrome. Although the family history was positive for macrocephaly, dysthyroidism, cancers, and autism, phosphatase and tensin homolog gene mutation in the proband resulted de novo.</p>
<p>Epilepsy occurs frequently in patients with autism and also in those with associated macrocephaly.<sup><xref ref-type="bibr" rid="bibr17-0883073811420296">17</xref></sup> It has been described that mental retardation, cerebral lesions and rare diseases associated with autism increase the risk of seizures. Moreover, in idiopathic autism, seizure occurrence remains higher than in general population, suggesting that autism itself increases the risk of epilepsy. In these cases, seizures could represent an epiphenomenon of a cerebral dysfunction independent of apparent lesions and do not seem to play a pathogenetic role in autism, but they can worsen the prognosis for behavior and cognition.<sup><xref ref-type="bibr" rid="bibr18-0883073811420296">18</xref></sup> Our patient presented 2 focal seizures that we controlled by means of antiepileptic treatment and which could be related to autism, to phosphatase and tensin homolog (PTEN) gene mutation, to perhaps a prenatal-perinatal injury in a macrosomic fetus or to all these findings combined.</p>
<p>We remark that in the literature there are no cases described of Cowden syndrome and autism with epilepsy or seizures. At the same time, only one of the described cases, showing phosphatase and tensin homolog gene mutation and autism, presented a severe epilepsy characterized by infantile spasms.<sup><xref ref-type="bibr" rid="bibr11-0883073811420296">11</xref></sup> At present, we need to study a larger cohort of cases to verify the hypothesis of a different prevalence of epilepsy in autism linked to phosphatase and tensin homolog gene mutation with respect to idiopathic autism.</p>
<p>The prevalence of Cowden syndrome has been estimated to be nearly 1/200 000; germline mutations in phosphatase and tensin homolog gene are generally reported to be found in 80% of patients with this syndrome.<sup><xref ref-type="bibr" rid="bibr19-0883073811420296">19</xref></sup> On the contrary, there are no data about the frequency of phosphatase and tensin homolog gene mutations in the general population, or about the prevalence of autism spectrum disorders in people with a phosphatase and tensin homolog gene mutation. To date, it has not been possible to determine if the occurrence of autism is greater in patients with phosphatase and tensin homolog gene mutation than in the general population. If a higher occurrence will be demonstrated, we could hypothesize a role of the phosphatase and tensin homolog gene in the brain development of patients with autism.</p>
<p>The genetic component of autism is complex and includes known chromosomal abnormalities, rare monogenic diseases and copy number variants.<sup><xref ref-type="bibr" rid="bibr20-0883073811420296">20</xref></sup> Since the list of described genetic and metabolic conditions that are associated with autism is quite extensive and continued advances in genetic technology expand the diagnostic options available for these evaluations,<sup><xref ref-type="bibr" rid="bibr21-0883073811420296">21</xref></sup> it is important to utilize a diagnostic protocol to exclude heterogeneous pathologies associated with autism. For example, phosphatase and tensin homolog gene mutation testing should be considered for patients with autism only in cases with a severe and progressive macrocephaly.<sup><xref ref-type="bibr" rid="bibr3-0883073811420296">3</xref><xref ref-type="bibr" rid="bibr4-0883073811420296"/>–<xref ref-type="bibr" rid="bibr5-0883073811420296">5</xref>,<xref ref-type="bibr" rid="bibr8-0883073811420296">8</xref><xref ref-type="bibr" rid="bibr9-0883073811420296"/><xref ref-type="bibr" rid="bibr10-0883073811420296"/>–<xref ref-type="bibr" rid="bibr11-0883073811420296">11</xref>,<xref ref-type="bibr" rid="bibr13-0883073811420296">13</xref>,<xref ref-type="bibr" rid="bibr14-0883073811420296">14</xref></sup>
</p>
<p>In conclusion, it seems important to report all new cases affected by phosphatase and tensin homolog gene mutation or Cowden syndrome for 2 reasons. First, it is relevant to detail all symptoms, most of all dermatologic, to allow for an early diagnosis as in our patient and we would like to stress the early onset of palmoplantar punctate keratoses since it has been suggested that this clinical presentation may be an initial cutaneous sign of phosphatase and tensin homolog gene mutation. Second, also neurological and psychiatric features should be reported regularly and thoroughly in patients affected by phosphatase and tensin homolog gene mutations and autism because, as reported in our case, autism and epileptic seizures need an early diagnosis to ensure an adequate rehabilitative and pharmacologic treatment.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgment</title>
<p>We thank Mr Massimo Armaroli for technical assistance.</p>
</ack>
<fn-group>
<fn fn-type="other" id="fn1-0883073811420296">
<p>SC, MC, and APos equally contributed to drafting the article and acquisition of data. APar contributed to drafting and revising the article. FM, NR, AR, IN, and APat equally contributed to revising the article and final approval of the version to be published.</p>
</fn>
<fn fn-type="conflict" id="fn2-0883073811420296">
<p>The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. </p>
</fn>
<fn fn-type="financial-disclosure" id="fn3-0883073811420296">
<p>The authors received no financial support for the research, authorship, and/or publication of this article. </p>
</fn>
<fn fn-type="other" id="fn4-0883073811420296">
<p>The research/writing of this article did not require ethical approval.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0883073811420296">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eng</surname>
<given-names>C.</given-names>
</name>
</person-group> <article-title>PTEN: one gene, many syndromes</article-title>. <source>Hum Mutat</source>. <year>2003</year>;<volume>22</volume>(<issue>3</issue>):<fpage>183</fpage>–<lpage>198</lpage>.</citation>
</ref>
<ref id="bibr2-0883073811420296">
<label>2</label>
<citation citation-type="book">
<collab collab-type="author">National Comprehensive Cancer Network</collab>.<article-title>The NCCN genetic/familial high-risk assessment: breast and ovarian (version 1.2008)</article-title>. <source>Clinical Practice Guidelines in Oncology</source>.<year>2008</year>;<publisher-loc>Fort Washington, PA</publisher-loc>: <publisher-name>National Comprehensive Cancer Network</publisher-name>, </citation>
</ref>
<ref id="bibr3-0883073811420296">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boccone</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dessì</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Zappu</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Bannayan-Riley Ruvalcaba syndrome with reactive nodular lymphoid hyperplasia and autism and a PTEN mutation</article-title>. <source>Am J Med Genet A</source>. <year>2006</year>;<volume>140</volume>:<fpage>1965</fpage>–<lpage>1969</lpage>.</citation>
</ref>
<ref id="bibr4-0883073811420296">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butler</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Dasouki</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>XP</given-names>
</name>
<etal/>
</person-group>. <article-title>Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations</article-title>. <source>J Med Genet</source>. <year>2005</year>;<volume>42</volume>(<issue>4</issue>):<fpage>318</fpage>–<lpage>321</lpage>.</citation>
</ref>
<ref id="bibr5-0883073811420296">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chaste</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly</article-title>. <source>Am J Med Genet B Neuropsychiatr Genet</source>. <year>2007</year>;<volume>44B</volume>(<issue>4</issue>):<fpage>484</fpage>–<lpage>491</lpage>.</citation>
</ref>
<ref id="bibr6-0883073811420296">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delatycki</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Danks</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Churchyard</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>XP</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>C.</given-names>
</name>
</person-group> <article-title>De novo germline PTEN mutation in a man with Lhermitte-Duclos disease which arose on the paternal chromosome and was transmitted to his child with polydactyly and Wormian bones</article-title>. <source>J Med Genet</source>. <year>2003</year>;<volume>40</volume>(<issue>8</issue>):<fpage>e92</fpage>.</citation>
</ref>
<ref id="bibr7-0883073811420296">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goffin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hoefsloot</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Bosgoed</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Swillen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fryns</surname>
<given-names>JP.</given-names>
</name>
</person-group> <article-title>PTEN mutation in a family with Cowden syndrome and autism</article-title>. <source>Am J Med Genet</source>. <year>2001</year>;<volume>105</volume>(<issue>6</issue>):<fpage>521</fpage>–<lpage>524</lpage>.</citation>
</ref>
<ref id="bibr8-0883073811420296">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herman</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Butter</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Enrile</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pastore</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Prior</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>A.</given-names>
</name>
</person-group> <article-title>Increasing knowledge of PTEN germline mutations: two additional patients with autism and macrocephaly</article-title>. <source>Am J Med Genet A</source>. <year>2007</year>;<volume>143</volume>(<issue>6</issue>):<fpage>589</fpage>–<lpage>593</lpage>.</citation>
</ref>
<ref id="bibr9-0883073811420296">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lynch</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Lynch</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>McMenamin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Webb</surname>
<given-names>D.</given-names>
</name>
</person-group> <article-title>Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay</article-title>. <source>Arch Dis Child</source>. <year>2009</year>;<volume>94</volume>(<issue>7</issue>):<fpage>553</fpage>–<lpage>554</lpage>.</citation>
</ref>
<ref id="bibr10-0883073811420296">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McBride</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Pastore</surname>
<given-names>MT</given-names>
</name>
<etal/>
</person-group>. <article-title>Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly</article-title>. <source>Autism Res</source>. <year>2010</year>;<volume>3</volume>(<issue>3</issue>):<fpage>137</fpage>–<lpage>141</lpage>.</citation>
</ref>
<ref id="bibr11-0883073811420296">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orrico</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Galli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Buoni</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Orsi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vonella</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Sorrentino</surname>
<given-names>V.</given-names>
</name>
</person-group> <article-title>Novel PTEN mutations in neurodevelopmental disorders and macrocephaly</article-title>. <source>Clin Genet</source>. <year>2009</year>;<volume>75</volume>(<issue>2</issue>):<fpage>195</fpage>–<lpage>198</lpage>.</citation>
</ref>
<ref id="bibr12-0883073811420296">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parisi</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Dinulos</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Leppig</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Sybert</surname>
<given-names>VP</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hudgins</surname>
<given-names>L.</given-names>
</name>
</person-group> <article-title>The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome</article-title>. <source>J Med Genet</source>. <year>2001</year>;<volume>38</volume>(<issue>1</issue>):<fpage>52</fpage>–<lpage>58</lpage>.</citation>
</ref>
<ref id="bibr13-0883073811420296">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stein</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Elias</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Saenz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pickler</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>A.</given-names>
</name>
</person-group> <article-title>Autistic spectrum disorder in a 9-year-old girl with macrocephaly</article-title>. <source>J Dev Behav Pediatr</source>. <year>2010</year>;<volume>31</volume>(<issue>7</issue>):<fpage>632</fpage>–<lpage>634</lpage>.</citation>
</ref>
<ref id="bibr14-0883073811420296">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varga</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Pastore</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Prior</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Herman</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>McBride</surname>
<given-names>KL.</given-names>
</name>
</person-group> <article-title>The prevalence of PTEN mutations in a clinical pediatric cohort with autism spectrum disorders, developmental delay, and macrocephaly</article-title>. <source>Genet Med</source>. <year>2009</year>;<volume>11</volume>(<issue>2</issue>):<fpage>111</fpage>–<lpage>117</lpage>.</citation>
</ref>
<ref id="bibr15-0883073811420296">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zori</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Marliss</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>C.</given-names>
</name>
</person-group> <article-title>Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome</article-title>. <source>Am J Med Genet</source>. <year>1998</year>;<volume>80</volume>(<issue>4</issue>):<fpage>399</fpage>–<lpage>402</lpage>.</citation>
</ref>
<ref id="bibr16-0883073811420296">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferran</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bussaglia</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Matias-Guiu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Pujol</surname>
<given-names>M.</given-names>
</name>
</person-group> <article-title>Bilateral and symmetrical palmoplantar punctate keratoses in childhood: a possible clinical clue for an early diagnosis of PTEN hamartoma-tumour syndrome</article-title>. <source>Clin Exp Dermatol</source>. <year>2009</year>;<volume>34</volume>(<issue>5</issue>):<fpage>e28</fpage>–<lpage>e30</lpage>.</citation>
</ref>
<ref id="bibr17-0883073811420296">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parmeggiani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Posar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Giovanardi-Rossi</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Andermann</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zifkin</surname>
<given-names>B.</given-names>
</name>
</person-group> <article-title>Autism, macrocrania and epilepsy: how are they linked?</article-title> <source>Brain Dev</source>. <year>2002</year>;<volume>24</volume>(<issue>5</issue>):<fpage>296</fpage>–<lpage>299</lpage>.</citation>
</ref>
<ref id="bibr18-0883073811420296">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parmeggiani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Barcia</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Posar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Raimondi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Santucci</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Scaduto</surname>
<given-names>MC.</given-names>
</name>
</person-group> <article-title>Epilepsy and EEG paroxysmal abnormalities in autism spectrum disorders</article-title>. <source>Brain Dev</source>. <year>2010</year>;<volume>32</volume>(<issue>9</issue>):<fpage>783</fpage>–<lpage>789</lpage>.</citation>
</ref>
<ref id="bibr19-0883073811420296">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pilarski</surname>
<given-names>R.</given-names>
</name>
</person-group> <article-title>Cowden syndrome: a clinical review of the clinical literature</article-title>. <source>J Genet Couns</source>. <year>2009</year>;<volume>18</volume>(<issue>1</issue>):<fpage>13</fpage>–<lpage>27</lpage>.</citation>
</ref>
<ref id="bibr20-0883073811420296">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pagnamenta</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Functional impact of global rare copy number variation in autism spectrum disorders</article-title>. <source>Nature</source>. <year>2010</year>;<volume>466</volume>(<issue>7304</issue>):<fpage>368</fpage>–<lpage>372</lpage>.</citation>
</ref>
<ref id="bibr21-0883073811420296">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaefer</surname>
<given-names>GB</given-names>
</name>
<name>
<surname>Mendelsohn</surname>
<given-names>NJ.</given-names>
</name>
</person-group> <article-title>Genetics evaluation for the etiologic diagnosis of autism spectrum disorders</article-title>. <source>Genet Med</source>. <year>2008</year>;<volume>10</volume>(<issue>1</issue>):<fpage>4</fpage>–<lpage>12</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>